Istituto Regina Elena; Oncologia Medica A
About Istituto Regina Elena; Oncologia Medica A
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
17
Consorzio Oncotech
2
Gruppo Oncologico Italiano di Ricerca Clinica
1
Pfizer
1
Puma Biotechnology, Inc.
1
University of Bologna
1
Clinical Trials at Istituto Regina Elena; Oncologia Medica A
During the past decade, Istituto Regina Elena; Oncologia Medica A conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 13 clinical trials were completed, i.e. on
average, 118.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
2009-02-04
2018-06-03
Completed
233
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
2007-08-30
2016-05-31
Completed
3,942
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
2011-01-13
2016-11-30
Completed
343
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)
2011-03-31
2017-01-31
Completed
50
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Istituto Regina Elena; Oncologia Medica A" #1 sponsor was "Hoffmann-La Roche" with 17 trials, followed by "Consorzio Oncotech" with 2 trials
sponsored, "Gruppo Oncologico Italiano di Ricerca Clinica" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Puma Biotechnology, Inc."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Regina Elena; Oncologia Medica A"
#1 collaborator was "AOU S.Orsola Malpighi-Unit of Oncologic Molecular and Transplantations Pathology" with 2 trials as a collaborator, "AOU S. Orsola Malpighi - Clinical Trial Office" with 1 trials as a collaborator, "Bioikos Ambiente Srl" with 1 trials as a collaborator, "Clinical Research Technology S.r.l." with 1 trials as a collaborator and "Ipsen" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Istituto Regina Elena; Oncologia Medica A
According to Clinical.Site data, the most researched conditions in "Istituto Regina Elena; Oncologia Medica A" are
"Breast Cancer" (3 trials), "Metastatic Breast Cancer" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Ovarian Cancer" (2 trials) and "Advanced BRAFV600 Wild-type Melanoma" (1 trials). Many other conditions were trialed in "Istituto Regina Elena; Oncologia Medica A" in a lesser frequency.
Clinical Trials Intervention Types at Istituto Regina Elena; Oncologia Medica A
Most popular intervention types in "Istituto Regina Elena; Oncologia Medica A" are "Drug" (22 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (6 trials), "Bevacizumab" (3 trials), "Cobimetinib" (3 trials), "Pertuzumab" (3 trials) and "Vemurafenib" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Istituto Regina Elena; Oncologia Medica A
The vast majority of trials in "Istituto Regina Elena; Oncologia Medica A" are
17 trials for "All" genders and 6 trials for "Female" genders.
Clinical Trials Status at Istituto Regina Elena; Oncologia Medica A
Currently, there are NaN active trials in "Istituto Regina Elena; Oncologia Medica A".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Istituto Regina Elena; Oncologia Medica A,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Istituto Regina Elena; Oncologia Medica A, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".